Trial record 1 of 2 for:
apitegromab
Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab-ONYX (ONYX)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05626855 |
|
Recruitment Status :
Active, not recruiting
First Posted : November 25, 2022
Last Update Posted : May 6, 2024
|
Sponsor:
Scholar Rock, Inc.
Information provided by (Responsible Party):
Scholar Rock, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | November 1, 2026 |
| Estimated Study Completion Date : | January 1, 2027 |